Research

Cellular

A dual/poly-GPCR agonism strategy has emerged as an alternative approach to the traditional mono-GPCR concept.

Practitioners may consider exploring dual/poly-GPCR strategies in obesity treatment.

StrongSupportsmedium confidence
Lately, a dual/poly-GPCR agonism strategy has emerged as an alternative approach to the traditional mono-GPCR concept.
Mohan Patil et al. · Biomedicine & Pharmacotherapy · 2024

Why this rating

The claim is based on a review of recent developments in GPCR research.

Source

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

Mohan Patil et al. · Biomedicine & Pharmacotherapy · 2024

DOI 10.1016/j.biopha.2024.116245

reviewCited 9×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →